<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tias Pramesti Griana</style></author><author><style face="normal" font="default" size="100%">Tri Yudani Mardining Raras</style></author><author><style face="normal" font="default" size="100%">Karyono Mintaroem</style></author><author><style face="normal" font="default" size="100%">Iin Noor Chozin</style></author><author><style face="normal" font="default" size="100%">Catur Saptaning Wilujeng</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Immunosuppressive Activity of Goat Kefir in a Rat Model with Bleomycin-induced Pulmonary Fibrosis</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Bleomycin</style></keyword><keyword><style  face="normal" font="default" size="100%">Cytokine</style></keyword><keyword><style  face="normal" font="default" size="100%">Immunomodulator</style></keyword><keyword><style  face="normal" font="default" size="100%">Kefir</style></keyword><keyword><style  face="normal" font="default" size="100%">Pulmonary fibrosis</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">November 2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">1594-1599</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Objective:&lt;/strong&gt; This study aimed to investigate the immunomodulatory capacity of goat kefir on pulmonary fibrosis rat model. &lt;strong&gt;Material and Methods: &lt;/strong&gt;Twenty-five male rats were randomly divided into five groups: one group only received induction with bleomycin (0.3 mg/rat) to induce pulmonary fibrosis; three groups were treated with different doses (2.5, 3.5, and 4.5 mL/200 g BW) of goat kefir, following the induction with bleomycin, for 30 days; and one group served as negative control, did not receive bleomycin induction as well as kefir. On day 30, all the animals were sacrificed. Plasma levels of TGF-β, IL-4, and IFN-y were measured using the ELISA method, and the expression of α-SMA in myofibroblast cells was examined with the help of immunohistochemistry assay. &lt;strong&gt;Results:&lt;/strong&gt; Induction with bleomycin significantly elevated the expressions of TGF-β, IL-4, and IFN-y in comparison to the control group. Following the administration of kefir (3.5 and 4.5 mL/200 g BW), the concentration of TGF-β was significantly decreased (p&amp;lt;0.05); whereas, the concentration of IFN-y increased slightly (p&amp;lt;0.05) only in the group that received the 4.5 mL/200 g BW dose of kefir. In contrast, IL-4 exhibited increasing levels with higher doses of kefir (p&amp;lt;0.05). The expression of α-SMA in myofibroblasts showed a tendency to decline following the administration of kefir, although this decline was not statistically significant.&lt;strong&gt; Conclusions:&lt;/strong&gt; Goat kefir caused a reduction in the TGF-β levels in fibrosis conditions; however, the kefir elicited an immunosuppressive effect during the progression of the pulmonary fibrosis.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6s</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">1594</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Tias Pramesti Griana&lt;sup&gt;1,2,&lt;/sup&gt;*, Tri Yudani Mardining Raras&lt;sup&gt;3&lt;/sup&gt;, Karyono Mintaroem&lt;sup&gt;4&lt;/sup&gt;, Iin Noor Chozin&lt;sup&gt;5&lt;/sup&gt;, Catur Saptaning Wilujeng&lt;sup&gt;6&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Anatomy, Faculty of Medicine and Health Science, State Islamic University Maulana Malik Ibrahim Malang, Jl. Gajayana No.50, Malang 65144, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Master Program on Biomedical Science, Faculty of Medicine, Brawijaya University, Jl. Veteran, Malang, Jawa Timur 65145, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Biochemistry and Molecular Biology, Faculty of Medicine, Brawijaya University, Jl. Veteran, Malang, Jawa Timur 65145, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Anatomical Pathology, Faculty of Medicine, Brawijaya University, Jl. Veteran, Malang, Jawa Timur 65145, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Department of Pulmonology, Saiful Anwar Hospital, Jl. Jaksa Agung Suprapto No.2, Malang 65112, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;Department of Nutrition, Faculty of Medicine, Brawijaya University, Jl. Veteran, Malang, Jawa Timur 65145, INDONESIA.&lt;/p&gt;
</style></auth-address></record></records></xml>